BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8657017)

  • 1. Prevention of vascular graft infection by sisomicin incorporated into fibrin glue.
    Yamamura K; Sakurai T; Yano K; Osada T; Nabeshima T
    Microbiol Immunol; 1995; 39(11):895-96. PubMed ID: 8657017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and serum concentration of sisomicin released from fibrin glue-sealed dacron graft in the rat and human.
    Osada T; Yamamura K; Yano K; Fujimoto K; Mizuno K; Sakurai T; Nabeshima T
    J Biomed Mater Res; 2000 Oct; 52(1):53-7. PubMed ID: 10906674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of graft infection by bonding of gentamycin to Dacron prostheses.
    Haverich A; Hirt S; Karck M; Siclari F; Wahlig H
    J Vasc Surg; 1992 Jan; 15(1):187-93. PubMed ID: 1530824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Riva A; Del Prete MS; Saba V; Scalise G
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2885-8. PubMed ID: 12183242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
    Morishima M; Marui A; Yanagi S; Nomura T; Nakajima N; Hyon SH; Ikeda T; Sakata R
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):52-5. PubMed ID: 20360210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
    Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
    Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
    Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
    Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
    Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
    Sardelic F; Ao PY; Taylor DA; Fletcher JP
    Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of early vascular graft infection using regional antibiotic release.
    Kuehn C; Graf K; Mashaqi B; Pichlmaier M; Heuer W; Hilfiker A; Stiesch M; Chaberny IF; Haverich A
    J Surg Res; 2010 Nov; 164(1):e185-91. PubMed ID: 20828762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
    Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
    BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations in the use of rifampicin-gelatin grafts against virulent organisms.
    Koshiko S; Sasajima T; Muraki S; Azuma N; Yamazaki K; Chiba K; Tachibana M; Inaba M
    J Vasc Surg; 2002 Apr; 35(4):779-85. PubMed ID: 11932679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts.
    Demirag MK; Esen S; Zivalioglu M; Leblebicioglu H; Keceligil HT
    Ann Vasc Surg; 2007 Jul; 21(4):464-7. PubMed ID: 17628264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-induced shock waves enhance sterilization of infected vascular prosthetic grafts.
    Nigri GR; Tsai S; Kossodo S; Waterman P; Fungaloi P; Hooper DC; Doukas AG; LaMuraglia GM
    Lasers Surg Med; 2001; 29(5):448-54. PubMed ID: 11891733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Kamysz W; Del Prete MS; Lukasiak J; Scalise G; Saba V
    J Vasc Surg; 2002 Nov; 36(5):1027-30. PubMed ID: 12422090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.